206 related articles for article (PubMed ID: 22242150)
1. CD44 expression in oro-pharyngeal carcinoma tissues and cell lines.
Rajarajan A; Stokes A; Bloor BK; Ceder R; Desai H; Grafström RC; Odell EW
PLoS One; 2012; 7(1):e28776. PubMed ID: 22242150
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
[TBL] [Abstract][Full Text] [Related]
3. CD44 staining of cancer stem-like cells is influenced by down-regulation of CD44 variant isoforms and up-regulation of the standard CD44 isoform in the population of cells that have undergone epithelial-to-mesenchymal transition.
Biddle A; Gammon L; Fazil B; Mackenzie IC
PLoS One; 2013; 8(2):e57314. PubMed ID: 23437366
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
5. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.
Athanassiou-Papaefthymiou M; Shkeir O; Kim D; Divi V; Matossian M; Owen JH; Czerwinski MJ; Papagerakis P; McHugh J; Bradford CR; Carey TE; Wolf GT; Prince ME; Papagerakis S
Int J Immunopathol Pharmacol; 2014; 27(3):337-49. PubMed ID: 25280025
[TBL] [Abstract][Full Text] [Related]
7. Differential expressions of CD44 variants in tumors affecting the central nervous system.
Resnick DK; Resnick NM; Welch WC; Cooper DL
Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
[TBL] [Abstract][Full Text] [Related]
8. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
Olsson E; Honeth G; Bendahl PO; Saal LH; Gruvberger-Saal S; Ringnér M; Vallon-Christersson J; Jönsson G; Holm K; Lövgren K; Fernö M; Grabau D; Borg A; Hegardt C
BMC Cancer; 2011 Sep; 11():418. PubMed ID: 21957977
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis.
Ue T; Yokozaki H; Kagai K; Higashikawa K; Yasui W; Sugiyama M; Tahara E; Ishikawa T
J Oral Pathol Med; 1998 May; 27(5):197-201. PubMed ID: 9682981
[TBL] [Abstract][Full Text] [Related]
10. Characterization of CD44 splicing patterns in normal keratinocytes, dysplastic and squamous carcinoma cell lines.
Bloor BK; Jelvagharan M; White KN; Odell EW
Int J Oncol; 2001 May; 18(5):1053-9. PubMed ID: 11295056
[TBL] [Abstract][Full Text] [Related]
11. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.
Fang XJ; Jiang H; Zhao XP; Jiang WM
BMC Cancer; 2011 Jul; 11():290. PubMed ID: 21749678
[TBL] [Abstract][Full Text] [Related]
12. CD44 expression is predictive of poor prognosis in pharyngolaryngeal cancer: systematic review and meta-analysis.
Chai L; Liu H; Zhang Z; Wang F; Wang Q; Zhou S; Wang S
Tohoku J Exp Med; 2014 Jan; 232(1):9-19. PubMed ID: 24429392
[TBL] [Abstract][Full Text] [Related]
13. Variant CD44 expression by human fibroblasts.
Rajarajan A; Bloor BK; Desai H; Stokes A; Odell EW
Biomarkers; 2008 May; 13(3):307-18. PubMed ID: 18415803
[TBL] [Abstract][Full Text] [Related]
14. Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression.
Wang SJ; Earle C; Wong G; Bourguignon LY
Head Neck; 2013 Apr; 35(4):511-20. PubMed ID: 22473523
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them.
Hudson DL; Speight PM; Watt FM
Int J Cancer; 1996 May; 66(4):457-63. PubMed ID: 8635860
[TBL] [Abstract][Full Text] [Related]
16. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
[TBL] [Abstract][Full Text] [Related]
17. Transcription and expression of CD44 variant exons by oro-pharyngeal squamous cell carcinomas.
Bloor BK; Rajarajan A; Jaafary-Haghighat K; Odell EW
Int J Oncol; 2002 Oct; 21(4):907-13. PubMed ID: 12239634
[TBL] [Abstract][Full Text] [Related]
18. CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
Sosulski A; Horn H; Zhang L; Coletti C; Vathipadiekal V; Castro CM; Birrer MJ; Nagano O; Saya H; Lage K; Donahoe PK; Pépin D
PLoS One; 2016; 11(6):e0156595. PubMed ID: 27253518
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.
Bánky B; Rásó-Barnett L; Barbai T; Tímár J; Becságh P; Rásó E
Mol Cancer; 2012 Nov; 11():83. PubMed ID: 23151220
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation stabilizes alternatively spliced CD44 mRNA transcripts in breast cancer cells: inhibition by antisense complementary to casein kinase II mRNA.
Formby B; Stern R
Mol Cell Biochem; 1998 Oct; 187(1-2):23-31. PubMed ID: 9788739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
